Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Sahane Biotech Inc
Profile last edited on: 7/13/17      CAGE: 7FUH6      UEI: L9TLJWV8XPC7

Business Identifier: Novel therapeutics for diabetes
Year Founded
2015
First Award
2016
Latest Award
2016
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

511 Street Johns Court
Oakbrook, IL 60523
   (312) 659-0041
   bprabhak@gmail.com
   N/A
Location: Single
Congr. District: 05
County: DuPage

Public Profile

Sahane Biotech is working to develop alternative treatments for diabetes based upon restoration of normal regulatory T cell function. The firm's recent studies have shown that soluble OX L and Jagged can cause a significant expansion of Tregs in vivo and suppress T D in mice. Sahane is seeking to validate these results and serve as basis for treatment of diabetes and other autoimmune disorders.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$260,665
Phase II Dollars
$0
Total Awarded
$260,665

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2016 1 NIH $260,665
Project Title: A Chimeric Protein for the Selective Expansion of Regulatory T Cells

Key People / Management

  Bellur S Prabhakar

Company News

There are no news available.